Alzinova: A Further (minor) delay
Earlier this week, Alzinova gave an updated timeline for when the first-in-man study with the Alzheimer vaccine candidate, ALZ-101, can start.
Sign up for free to continue
Already a member?
Disclosures and disclaimers
Premium Plan required to unlock